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The aim of this systematic review was to document efficacy, safety and quality of evidence
of analgesic interventions after total knee arthroplasty (TKA).
Methods
This PRISMA-compliant and PROSPERO-registered review includes all-language random-
ized controlled trials of medication-based analgesic interventions after TKA. Bias was evalu-
ated according to Cochrane methodology. Outcomes were opioid consumption (primary),
pain scores at rest and during mobilization, adverse events, and length of stay. Interventions
investigated in three or more trials were meta-analysed. Outcomes were evaluated using
forest plots, Grading of Recommendations Assessment, Development and Evaluation
(GRADE), L’Abbe Plots and trial sequential analysis.
Results
The included 113 trials, investigating 37 different analgesic interventions, were character-
ized by unclear/high risk of bias, low assay sensitivity and considerable differences in pain
assessment tools, basic analgesic regimens, and reporting of adverse events. In meta-anal-
yses single and continuous femoral nerve block (FNB), intrathecal morphine, local infiltration
analgesia, intraarticular injection of local anaesthetics, non-steroidal anti-inflammatory
drugs, and gabapentinoids demonstrated significant analgesic effects. The 24-hour mor-
phine-sparing effects ranged from 4.2 mg (CI: 1.3, 7.2; intraarticular local anaesthetics), to
16.6 mg (CI: 11.2, 22; single FNB). Pain relieving effects at rest at 6 hours ranged from 4
mm (CI: -10, 2; gabapentinoids), to 19 mm (CI: 8, 31; single FNB), and at 24 hours from 3
mm (CI: -2, 8; gabapentinoids), to 16 mm (CI: 8, 23; continuous FNB). GRADE-rated quality
of evidence was generally low.
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Conclusion
A low quality of evidence, small sample sizes and heterogeneity of trial designs prohibit des-
ignation of an optimal procedure-specific analgesic regimen after TKA.
Introduction
The primary goals of postoperative analgesic treatment are to reduce pain, opioid require-
ments and consequently opioid-related adverse events, in order to optimize rehabilitation.
Enhancing these outcomes has potential beneficial influence on patient morbidity and satisfac-
tion, the degree of required postoperative care, as well as economic perspectives. Total knee
arthroplasty (TKA) is a frequently performed orthopedic procedure followed by moderate to
severe pain. Therefore, an efficient postoperative analgesic treatment based on sound evidence
from the published literature is important for this procedure [1]. Recent research on postoper-
ative pain after total hip arthroplasty suggest, however, that it may be difficult to allow a desig-
nation of a “best proven intervention” from the available scientific evidence [2], and it is
reasonable to believe that this applies for TKA as well.
The hypothesis of this review was, that no globally recognized, best proven, gold standard
analgesic treatment or intervention exists for TKA. The aim of this systematic review of all ran-
domized, controlled clinical trials (RCTs) considering postoperative pain treatment after TKA
is therefore to document the evidence for postoperative analgesic interventions after TKA.
Materials and methods
The review meets requirements of the Preferred Reporting Items for Systematic reviews and
Meta-Analyses (PRISMA) statement [3]. Registration in the PROSPERO International pro-
spective register of systematic reviews was completed on April 23, 2014, prior to initiation of
the study (registration number: CRD42014014940). Updated searches were carried out on
June 17, 2016, and September 19, 2016, and registered in the protocol as amendments.
Our methods are similar to those reported in a recent review of postoperative pain treat-
ment after total hip arthroplasty (THA) published by our research group [2]. As the two
reviews are associated the methods and results sections are reported in a similar way to secure
uniformity.
Literature search
Trials were sought in Pubmed, Embase and The Cochrane Library according to S1 Appendix.
The last search date was September 9, 2016. The PROSPECT database [4] and reference lists
were screened for eligible trials as well.
Inclusion criteria
Inclusion criteria were randomized controlled trials of unilateral total knee arthroplasty that
compared postoperative analgesic outcomes of a perioperative analgesic intervention against
placebo in a control group. Basic analgesic regimens and rescue analgesics had to be adminis-
tered under equal conditions in the intervention and control groups. Trials where different
rescue analgesics were administered, e.g. morphine and acetaminophen p.n., were included
for qualitative analyses, but not meta-analyses. We only included trials with interventions initi-
ated in the immediate perioperative period that reported either opioid-sparing effect, pain at
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rest or pain during mobilization. Trials concerning knee fractures, trials including patients less
than 18 years, and data published in summary clinical trials, editorials, letters, and comments
were excluded.
Outcomes
The primary outcome was 0–24 hours postoperative cumulated opioid consumption.
Secondary outcomes were pain both at rest and on mobilization at 6 and 24 hours postoper-
atively, opioid related and intervention associated adverse events, and length of hospital stay
(LOS).
Data extraction
We extracted the following data: Trial sample size; basic analgesic regimen (i.e. analgesics
administered to both intervention- and control group as a fixed regimen); rescue analgesics
and 24 hour cumulated dose; pain score at rest and during movement at 6 ± 2 hours and
24 ± 4 hours postoperatively; opioid-related adverse events (postoperative nausea or vomiting
(PONV), sedation, dizziness, pruritus, urinary retention, constipation and respiratory depres-
sion); intervention-associated adverse events as reported; LOS; and documented and prede-
fined discharge criteria.
Assay sensitivity (a trials ability to detect an absolute difference between groups if there is
one) was deemed low if a control group demonstrated a pain score on a visual analogue scale
(VAS 0–100 mm) below 30 mm and/or a 0–24 hour cumulated i.v. morphine consumption
below 15 mg.
Data extraction and bias evaluation was carried out by two authors independently. Dis-
agreements were solved during meetings with all authors.
Missing data
For trials with unclear bias domains or missing information regarding primary outcomes, the
corresponding author was contacted by email and if unresponsive, another inquiry was sent
two weeks later. We used open questions as "Please describe all measures taken to secure ran-
dom sequence allocation" to avoid false confirmation on suggested measures.
Bias assessment
We used the Cochrane bias assessment tool [5] to evaluate the following domains: Random
sequence allocation, allocation concealment, blinding of participants and personnel, blind-
ing of outcome assessors, incomplete outcome data, selective outcome reporting, and other
potential threats to validity (including conflict of interest). Domains were rated as low,
high, or unclear risk of bias. If all domains were low the summarized risk of bias was rated
low; if one or more domains were high the summarized risk was rated high; and if one or
more domains were unclear with no high risk domains, the summarized risk was rated
unclear.
In addition, we evaluated trial sample size as a contributor to bias. A cumulated trial sample
size of< 50 patients was rated as high risk of bias, 50–199 as moderate risk of bias, 200–499 as
low risk of bias, and> 499 as very low risk of bias based on Dechartres et al. [6].
Data analysis
Handling of data. Meta-analyses were carried out in Review Manager 51 [7] whenever
three or more trials regarding a specific intervention reported a 0–24 hour opioid
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consumption. Opioids were converted to i.v. morphine equivalents according to S2 Appendix.
Pain scores, side effects and LOS were analyzed when reported in three ore more trials. Visual
analogue scale (VAS 0–10) and Numerical Rating Scale 0–10 (NRS 0–10), were converted to
VAS 0–100. Median and interquartile range (IQR)/range was converted to mean and standard
deviation according to The Cochrane Handbook 7.7.3.5 [8], or Hozo et al [9], as appropriate.
For results presented only as mean, a standard deviation was calculated from the p-value
according to The Cochrane Handbook 7.7.3.3 [8], and we used the conservative approach
p = 0.05 if the p-value was expressed as p< 0.05. Some trials had more than one intervention
group. In these cases we either merged intervention groups or split the control group, accord-
ing to The Cochrane Handbook 7.7.a [8].
Forest plots were calculated with a 95% confidence interval (CI) mean difference for contin-
uous data and risk ratio (RR) with a 95% CI for dichotomous data. Random effects model was
used whenever I^2 was above 30%. For I^2 between 0 and 30% fixed and random effects mod-
els were compared and the most conservative approach (the model with the widest 95% CI)
was used to take into account the heterogeneity of included trials. P-values of less than 0.05
were considered statistically significant.
Heterogeneity. L’Abbe´ plots were conducted for each meta-analysed intervention to
describe the degree of heterogeneity for morphine consumption and pain scores [10].
Strength of evidence. In meta-analyses, low information size (number of patients
included) and repeated significance testing increase the risk of type I and II errors (false posi-
tive and false negative results, respectively). This risk can be reduced by performing trial
sequential analysis (TSA) [11]. A forest plot describes whether the tested intervention reaches
significance through the classic p<0.05, whereas TSA accounts for interim analyses and the
heterogeneity of the trials as well. In TSA, the normal stationary threshold for significance
with a Z-score at 1.96 for p = 0.05 is penalized if the included trials demonstrates a high degree
of heterogeneity. An intervention with a high degree of heterogeneity requires a higher infor-
mation size to reach the threshold for significance compared to a forest plot analysis. This is
calculated as the a priori estimated information size (APIS).
TSA was performed for morphine consumption and pain scores, for all interventions that
were included in meta-analyses.
We used Trial Sequential Analysis Viewer 0.9 Beta (The Copenhagen Trial Unit (CTU))
and followed the CTU guidelines (an alpha-value of 0.05 and a beta-value of 0.9) [12]. The sen-
sitivity to detect a mean difference was set to 10 mg i.v. morphine equivalents/24 hours and 15
mm on a VAS 0–100 mm scale [13, 14].
Summary of findings. Quality of evidence was assessed with The Grading of Recommen-
dations Assessment, Development and Evaluation (GRADE). Five factors were evaluated for
each outcome: Study limitations; publication bias; indirectness of evidence; inconsistent
results; and imprecision (evaluation based on results in TSA) [15].




Search on Pubmed, EMBASE and The Cochrane Library identified 5126, 5806 and 2646 cita-
tions, respectively. The first author removed 4952 duplicates. Two authors assessed the
remaining 8626 citations individually, compared results and consequently 287 trials were
downloaded in full-text, of which 22 were written in a non-English language. We managed to
acquire 285 trials of which 172 met one or more exclusion criteria (S3 Appendix).
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Thus, 113 randomized placebo-controlled trials concerning postoperative analgesic inter-
ventions after TKA were included for review (Fig 1 PRISMA flowchart). The total number of
patients was 8407.
The included trials comprised 37 different treatment interventions. Interventions that qual-
ified for meta-analyses, were single injection femoral nerve block (FNB), continuous FNB,
intrathecal morphine, local infiltration analgesia (LIA), intraarticular injection with local
anaesthetics, non-steroidal anti-inflammatory drugs (NSAIDs)/COX-2-inhibitors, and
gabapentinoids.
Of all trials 36, 10, 3, and 1 had two, three, four and five separate intervention groups,
respectively.
The follow-up period in the included trials was: 1 day in 20 trials, 2 days in 36 trials, 3 days
in 16 trials, 4–7 days in 8 trials,2 weeks in 22 trials, and unclear in 11 trials.
Detailed study information from the included trials is summarized in Table 1.
Risk of bias in included trials
105 trials contained at least one unclear domain (a total of 350 unclear domains). We con-
tacted the corresponding authors by email. Email addresses were either irretrievable or perma-
nently out of use in 22 trials. Corresponding authors for the remaining 83 trials were
contacted. Forty authors replied regarding 119 unclear domains and 74 were resolved (5 high
and 69 low). Forty-four domains remained unclear.
The summarized risk of bias was low in 18 trials, unclear in 65 and high in 30 (Fig 2). Fur-
ther, the trial sample size bias was high in 41 trials, moderate in 69, and low or lower in three.
Supplemental and basic analgesic regimens
Sixty trials administered i.v. morphine patient-controlled analgesia (PCA) as rescue medica-
tion, and reported a 0–24 hours cumulated consumption, while the remaining 53 trials admin-
istered i.v./i.m. fentanyl, oxycodone, hydromorphone, meperidine, papaveretum (a mixture of
morphine, papaverine, and codeine), sufentanil or NSAIDs; patient-controlled continuous
FNB; or epidural local anaesthetics/opioids. Eighty-nine trials reported cumulated opioid con-
sumption over 20–72 hours postoperatively, seven of these also administered a second non-
opioid rescue analgesic. In five trials included in meta-analyses, other types of opioids were
converted to i.v. morphine equivalents. Postoperative 0–24 hours morphine consumption in
the control groups for trials included in the meta-analyses ranged from 5.5–116 mg with a cor-
rected mean of 33.1 mg per patient.
A supplemental opioid with no underlying basic analgesic regimen, was administered in 37
trials. Sixty-three trials administered a basic analgesic regimen in addition to supplemental res-
cue analgesics; seven trials administered acetaminophen, 13 trials NSAIDs, 12 trials acetamin-
ophen + NSAID, seven trials local injection + other analgesics, 15 trials nerve blocks + other
analgesics, and 11 trials administered different combinations of analgesics (Table 1).
Pain scores
Pain score was reported as VAS 0–100 in 42 trials; as VAS 0–10 in 52 trials; and as either
numerical rating scale 0–10 (NRS 0–10), WOMAC pain scale 0–10, or verbal pain scale (VPS)
0–3 in 18 trials (S4 Appendix). After conversion to VAS 0–100 mm equivalents values in con-
trol groups ranged from 0–80 mm and 0–82 mm at rest and during mobilization, respectively.
Mean pain scores in control groups for trials included in the meta-analyses were 38 mm at 6
hours rest, 33 mm at 24 hours rest, 50 mm at 6 hour movement, and 53 mm at 24 hours
movement.
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Fig 1. Flow chart of trial selection. From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for
Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097. For more
information, visit www.prisma-statement.org.
doi:10.1371/journal.pone.0173107.g001
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Fig 2. Risk of bias in included studies. Green plus is low risk, yellow question mark is unclear risk, and red
minus is high risk of bias. Slanted lines indicate that the trial is part of both surrounding subgroups. * Indicates
that information regarding the bias domain has been reevaluated after obtaining an elaboration from the
corresponding author of the trial.
doi:10.1371/journal.pone.0173107.g002
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Pain scores at rest at 6 hours postoperatively were reported in 84 trials, and at 24 hours
postoperatively in 89 trials. Pain during mobilization was reported in 33 trials at 6 hours post-
operatively, and in 42 trials at 24 hours postoperatively (S4 Appendix).
Other outcomes
Ninety trials reported PONV, 24 sedation, 16 dizziness, and 43 pruritus (S4 Appendix).
LOS was reported in 36 trials of which 15 described clearly predefined discharge criteria.
No trials before 2001 reported LOS. Of the 36 trials six demonstrated a statistically significant
reduction in LOS.
Nineteen trials demonstrated low assay sensitivity for pain score (i.e. pain scores below 30
mm in control groups at 6 or 24h postoperatively). Thirteen trials demonstrated low assay sen-
sitivity for morphine consumption (i.e. no morphine consumption above 15 mg i.v. morphine
equivalents 0–24 hours postoperatively in control groups).
Results related to specific interventions
Seven meta-analyses were carried out. Forest plots for primary and secondary outcomes are
presented in Figs 3–5 and S5–S11 Appendices, L’Abbe´ plots and TSA are presented in S12–
S25 Appendices.
Fig 6 presents a summary of all the meta-analysed subgroups regarding outcomes,
GRADE-rated quality of evidence and the estimated risk of bias of the included trials.
Single injection femoral nerve block. Fifteen trials tested single FNB as an intervention
[16–30]. Four of these trials tested the intervention in addition to a basic analgesic regimen.
The summarized risk of bias was low in zero, unclear in 10, and high in five trials (Fig 2),
and the trial sample size implicated a high risk of bias in seven trials, and a moderate risk in
eight trials. L’Abbe´ plots demonstrated a lower degree of heterogeneity for pain score at rest
and moderate degrees for morphine consumption and pain during movement (S12
Appendix).
Meta-analyses demonstrated a statistically significant 0–24 hour postoperative morphine
sparing effect of 16.6 mg (95% CI: 11 to 22; p<0.00001) (Fig 3), and a reduction in postopera-
tive pain scores at 6 hours at rest of 19 mm (8 to 31; P = 0.0007), at 24 hours at rest of 12 mm
(5 to 19; P = 0.001), and at 24 hours during movement of 9 mm (-2 to 20; P = 0.09) (Figs 4 and
5, S6 Appendix).
In TSA, reductions in both morphine consumption and pain scores at rest at 6 and 24
hours were above the threshold for significance. Morphine consumption and 24 hours pain
score at rest reached APIS concluding that single FNB has a positive effect on these outcomes
(S13 Appendix).
In meta-analyses, RR for nausea and vomiting was 0.66 (0.51 to 0.85; P = 0.002), for dizzi-
ness 0.38 (0.12 to 1.19; P = 0.1) and for pruritus 0.94 (0.51 to 1.75; P = 0.85) (S7, S9 and S10
Appendices).
Urinary retention was registered in four trials [17, 19, 21, 22], deep venous thrombosis
(DVT) in two [17, 21], soreness/pain in the back in two [18, 23], hypotension in one [25],
numbness around the knee in one [16], and infection around the site of injection in one [26].
No significant differences between active and control groups were reported.
Quality of evidence (GRADE) was moderate for PONV; low for the opioid sparing effect
and pain scores and pruritus; and very low for dizziness. Results are summarized in Table 2.
Various local anaesthetics +/- epinephrine were administered in the trials (Table 1). The
evidence did not provide information about optimal drug-, and dose-regimens.
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Fig 3. 0–24 hour morphine consumption. Forest plot displaying mean difference in 0–24 hour morphine consumption for
each meta-analyzed intervention. Green squares with horizontal lines represent mean differences and 95% confidence
intervals for each trial. Black tiles represent the mean difference of each intervention.
doi:10.1371/journal.pone.0173107.g003
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Fig 4. 6 hours pain scores. Forest plot displaying mean difference in pain scores 6 hours postoperative at rest for each meta-analyzed intervention.
Green squares with horizontal lines represent mean differences and 95% confidence intervals for each trial. Black tiles represent the mean difference
of each intervention.
doi:10.1371/journal.pone.0173107.g004
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Fig 5. 24 hours pain scores. Forest plot displaying mean difference in pain scores 24 hours postoperative at rest for each meta-analyzed
intervention. Green squares with horizontal lines represent mean differences and 95% confidence intervals for each trial. Black tiles represent
the mean difference of each intervention.
doi:10.1371/journal.pone.0173107.g005
Postoperative pain treatment after TKA
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Continuous femoral nerve block
Ten trials tested continuous FNB as an intervention [30–39]. Six of these trials tested the inter-
vention in addition to a basic analgesic regimen.
The summarized risk of bias was low in zero, unclear in two, and high in eight trials (Fig 2),
and the trial sample size implicated a high risk of bias in four trials and a moderate risk in six.
L’Abbe´ plots demonstrated homogeneity for morphine consumption and pain scores (S14
Appendix).
Meta-analyses demonstrated a statistically significant 0–24 hour postoperative morphine
sparing effect of 12.3 mg (95% CI: 9.7 to 14.8; P<0.00001) (Fig 3), and a reduction in pain
scores at rest at 6 hours postoperatively of 10 mm (2 to 19; P = 0.01), at 24 hours at rest of 16
mm (8 to 23; P<0.00001) and at 24 hours during movement of 10 mm (4 to 15; P = 0.0005)
(Figs 4 and 5, S6 Appendix).
In TSA, reductions in both morphine consumption and pain scores at rest at 6 hours and
24 hours, and pain scores during movement at 24 hours, were above the threshold for signifi-
cance and reached APIS, concluding that continuous femoral nerve block has a positive effect
on these outcomes (S15 Appendix).
Fig 6. Efficacy, quality of evidence and risk of bias. A summary of each meta-analyzed intervention regarding the effect on each outcome (opioid
sparing effect in i.v. morphine equivalents mg, pain scores, and side effects), the GRADE-rated quality of evidence for each outcome and the estimated
risk of bias of the included trials. The bold numbers are mean reductions for the relevant outcome, below each bold number is the 95% confidence
interval, the p-value and the quality of evidence. Below each intervention the number of trials investigating the specific intervention is depicted. The
colored bars to the right depict the distribution of summarized risk of bias for the included trials. Not all trials investigated all relevant outcomes.
GRADE: The Grading of Recommandations Assessment, Development and Evaluation.
doi:10.1371/journal.pone.0173107.g006
Postoperative pain treatment after TKA
PLOS ONE | DOI:10.1371/journal.pone.0173107 March 8, 2017 25 / 53
In meta-analyses, RR for nausea and vomiting was 0.74 (0.54 to 1.03, P = 0.07), for sedation
1.33 (0.13 to 13.66; P = 0.81) and for pruritus 1.13 (0.9 to 1.41; P = 0.31) (S7, S8 and S10
Appendices). One study demonstrated a significant increase in obturator motor blockade at 6
hours postoperatively [33]. Urinary retention was registered in one trial [35], cardiac events in
one [38] and hypotension in two [35, 37]. No significant differences between active and con-
trol groups were reported.
Quality of evidence (GRADE) was moderate for reduction in morphine consumption and
pain score at 24 hours during movement; low for 24 hours pain score at rest, PONV and
Table 2. Summarized outcomes in Grading of Recommendations Assessment, Development and Evaluation (GRADE) for each major
intervention.
Table 2 summary of findings:
Single femoral nerve block compared to Placebo or no intervention for pain after TKA
Patient or population: pain after TKA. Setting: The immediate postoperative period. Intervention: Single femoral nerve block. Comparison: Placebo or
no intervention








(GRADE)Risk with Placebo or nointervention
Risk with Single femoral nerve block
Morphine consumption
assessed with: 0–24 hour
postoperative
The mean morphine
consumption was 32.2 mg
The mean morphine consumption in the
intervention group was 16.6 mg lower
(11.2 lower to 22 lower)
- 439 (7 RCTs) ⊕⊕◯◯ LOW a,b
Pain score 6 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 6 h
postoperative at rest was
43 mm
The mean pain score 6 h postoperative
at rest in the intervention group was 19
mm lower (8 lower to 31 lower)
- 474 (7 RCTs) ⊕⊕◯◯ LOW a,b
Pain score 24 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 24 h
postoperative at rest was
29 mm
The mean pain score 24 h postoperative
at rest in the intervention group was 12
mm lower (5 lower to 19 lower)
- 520 (9 RCTs) ⊕⊕◯◯ LOW a,b
Pain score 24 h postoperative
at movement assessed with:
VAS 0–100
The mean pain score 24 h
postoperative at
movement was 52 mm
The mean pain score 24 h postoperative
at movement in the intervention group
was 9 mm lower (20 lower to 2 higher)




with: Number of events
279 per 1,000 184 per 1,000 (142 to 237) RR 0.66
(0.51 to
0.85)




234 per 1,000 89 per 1,000 (28 to 278) RR 0.38
(0.12 to
1.19)




113 per 1,000 106 per 1,000 (57 to 197) RR 0.94
(0.51 to
1.75)
464 (6 RCTs) ⊕⊕◯◯ LOW a,d
Length of stay (LOS) The mean length of stay
was 5.5 days
The mean length of stay in the
intervention group was 0.3 days lower
(0.9 lower to 0.3 higher)
- 332 (5 RCTs) ⊕◯◯◯VERY
LOW a,b,d,e
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the
intervention (and its 95% CI). CI: Confidence interval; MD: Mean difference; RR: Risk ratio
GRADE Working Group grades of evidence: High quality: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from
the estimate of the effect Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from
the estimate of effect
a. There were studies of unclear and high summarized risk of bias.
b. There was heterogeneity as noted by I^2.
c. The intervention did not reach either threshold for significance or a priori estimated information size in trial sequential analysis.
d. 95% confidence interval includes ’no effect’.
e. There were less than 400 participants in total.
doi:10.1371/journal.pone.0173107.t002
Postoperative pain treatment after TKA
PLOS ONE | DOI:10.1371/journal.pone.0173107 March 8, 2017 26 / 53
pruritus; and very low for 6 hours pain score at rest and sedation. Results are summarized in
Table 3.
Various local anaesthetics +/- epinephrine were administered in all trials (Table 1). The evi-
dence did not allow designation of optimal drug-, and dose-regimens.
Table 3. Summarized outcomes in Grading of Recommendations Assessment, Development and Evaluation (GRADE) for each major
intervention.
Table 3 summary of findings:
Continuous femoral nerve block compared to Placebo or no intervention for pain after TKA
Patient or population: pain after TKA. Setting: The immediate postoperative setting. Intervention: Continuous femoral nerve block. Comparison:
Placebo or no intervention








(GRADE)Risk with Placebo or nointervention
Risk with Continuous femoral nerve
block
Morphine consumption
assessed with: 0–24 hour
postoperative
The mean morphine
consumption was 20.5 mg
The mean morphine consumption in the
intervention group was 12.3 mg lower
(9.7 lower to 14.8 lower)
- 264 (6 RCTs) ⊕⊕⊕◯
MODERATE a
Pain score 6 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 6 h
postoperative at rest was
20 mm
The mean pain score 6 h postoperative
at rest in the intervention group was 10
mm lower (2 lower to 19 lower)
- 308 (6 RCTs) ⊕◯◯◯VERY
LOW a,b,c,d
Pain score 24 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 24 h
postoperative at rest was
33 mm
The mean pain score 24 h postoperative
at rest in the intervention group was 16
mm lower (8 lower to 23 lower)
- 404 (8 RCTs) ⊕⊕◯◯ LOW
a,b,e
Pain score 24 h postoperative
at movement assessed with:
VAS 0–100
The mean pain score 24 h
postoperative at
movement was 64 mm
The mean pain score 24 h postoperative
at movement in the intervention group
was 10 mm lower (4 lower to 15 lower)




with: Number of events
580 per 1,000 429 per 1,000 (313 to 597) RR 0.74
(0.54 to
1.03)




286 per 1,000 380 per 1,000 (37 to 1,000) RR 1.33
(0.13 to
13.66)




507 per 1,000 573 per 1,000 (457 to 716) RR 1.13
(0.90 to
1.41)
175 (3 RCTs) ⊕⊕◯◯ LOW
a,c,f
Length of stay (LOS) The mean length of stay
was 6.4 days
The mean length of stay in the
intervention group was 0.3 days lower
(0.8 lower to 0.2 higher)
- 171 (3 RCTs) ⊕⊕◯◯ LOW
a,c,f
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the
intervention (and its 95% CI). CI: Confidence interval; MD: Mean difference; RR: Risk ratio
GRADE Working Group grades of evidence: High quality: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different. Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from
the estimate of the effect. Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from
the estimate of effect.
a. There were studies of unclear and high summarized risk of bias.
b. There was heterogeneity as noted by I^2.
c. There were less than 400 participants in total.
d. The intervention did not reach either threshold for significance or a priori estimated information size in trial sequential analysis.
e. Low assay sensitivity in Seet et al explains the heterogeneity.
f. 95% confidence interval includes ’no effect’.
doi:10.1371/journal.pone.0173107.t003
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Intrathecal morphine adjunct to local anaesthetics
Nine trials tested intrathecal morphine as an intervention [39–47]. Four of these trials tested
the intervention in addition to a basic analgesic regimen.
The summarized risk of bias was low in zero, unclear in six, and high in three trials (Fig 2),
and the trial sample size implicated a high risk of bias in two trials and a moderate risk in
seven. L’Abbe´ plots demonstrated moderate degrees of heterogeneity for morphine consump-
tion and pain scores (S16 Appendix).
Meta-analyses demonstrated a statistically significant 0–24 hour postoperative morphine
sparing effect of 9.8 mg (95% CI: 3.6 to 16.1, P = 0.002) (Fig 3), a reduction in pain scores at
rest at 6 hours postoperatively of 15 mm (1 to 28, P = 0.04), and at 24 hours at rest of 8 mm (0
to 17; P = 0.05) (Figs 4 and 5).
In TSA, morphine consumption reached the threshold for significance but not APIS. Pain
score at 24 hours rest reached the boundary for futility and APIS concluding that there is no
reason for further investigation of this outcome (S17 Appendix).
In meta-analyses, RR for nausea and vomiting was 1.8 (1.28 to 2.54; P = 0.0008), for seda-
tion 1.93 (0.18 to 20.24; P = 0.58) and for pruritus 5.74 (2.44 to 13.47; P<0.0001) (S7, S8 and
S10 Appendices). Hypoxemia was registered in one trial [41], respiratory depression in two
[41, 47], urinary retention in three [42, 43, 45] and anxiety in one [47]. No significant differ-
ences between active and control groups were reported.
Quality of evidence (GRADE) was high for the increase in pruritus; moderate for increase
in PONV; low for opioid sparing effect and reduction in pain score at 6 and 24 hours at rest;
and very low for the increase in sedation. Results are summarized in Table 4.
Diamorphine was administered in one trial and morphine in the others. Due to heterogene-
ity amongst trials there were no dose-response relationship and the evidence did not provide
information regarding optimal dosages.
Local Infiltration Analgesia (LIA)
Eighteen trials tested LIA as an intervention [48–65]. Thirteen of these trials tested the inter-
vention in addition to a basic analgesic regimen.
The summarized risk of bias was low in one, unclear in 12, and high in five trials (Fig 2),
and the trial sample size implicated a high risk of bias in six trials, a moderate risk in 11 and a
low risk in one. L’Abbe´ plots demonstrated low degrees of heterogeneity for morphine con-
sumption and pain scores at rest. Moderate degrees were present for pain scores during move-
ment (S18 Appendix).
Meta-analyses demonstrated a statistically significant 0–24 hour postoperative morphine
sparing effect of 13.4 mg (95% CI: 8.5 to 18.2; P<0.00001) (Fig 3), and a reduction in pain scores
at rest at 6 hours postoperatively of 14 mm (9 to 20; P<0.00001), at 24 hours rest of 10 mm (6 to
13; P<0.00001), at 6 hours during movement of 16 mm (9 to 23; P<0.00001) and at 24 hours
during movement of 14 mm (8 to 20; P<0.00001) (Figs 4 and 5, S5 and S6 Appendices).
In TSA, threshold for significance and APIS were reached for all outcomes, concluding that
LIA has a positive effect on these outcomes (S19 Appendix).
In meta-analyses RR for nausea and vomiting was 0.68 (0.54 to 0.86; P = 0.0009) and for
pruritus 0.78 (0.45 to 1.33; P = 0.36) (S7 and S10 Appendices). One study demonstrated a sig-
nificant reduction in blood loss [55] and one demonstrated a significant increase in skin blis-
ters due to cannula [59]. Hypotension was registered in one trial [50], respiratory distress/
depression in two [50, 64], headache in one [50], positive cultures from the catheter tips in
one [51], rash in one [52], urinary retention in seven [52, 54, 59–62, 64], DVT in four
[52, 61, 63, 64], incision complications in three [52, 54, 55], cardiac or CNS events in two
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[55, 63], slight numbness in one [56] and constipation in one [62]. No significant differences
between active and control groups were reported.
Quality of evidence (GRADE) was moderate for PONV; low for the opioid sparing effect
and reduction in pain scores, and very low for pruritus. Results are summarized in Table 5.
Trials were too heterogeneous (administration of different combinations of local anaes-
thetics, morphine, NSAIDs, steroids and epinephrine, Table 1) to provide information about
optimal drug-, and dose-regimens.
Intraarticular injection of local anaesthetics
Seven trials tested intraarticular injection of local anaesthetics as an intervention [65–71]. Two
of these trials tested the intervention in addition to a basic analgesic regimen.
Table 4. Summarized outcomes in Grading of Recommendations Assessment, Development and Evaluation (GRADE) for each major
intervention.
Table 4 summary of findings:
Intrathecal morphine compared to Placebo or no intervention for pain after TKA
Patient or population: pain after TKA. Setting: The immediate postoperative setting. Intervention: Intrathecal morphine. Comparison: Placebo or no
intervention.








(GRADE)Risk with Placebo or nointervention
Risk with Intrathecal morphine
Morphine consumption
assessed with: 0–24 hour
postoperative
The mean morphine
consumption was 23.6 mg
The mean morphine consumption in
the intervention group was 9.8 mg
lower (3.6 lower to 16.1 lower)
- 172 (4 RCTs) ⊕⊕◯◯ LOW a,b
Pain score 6 h postoperative at
rest assessed with: VAS 0–100
The mean pain score 6 h
postoperative at rest was
27 mm
The mean pain score 6 h postoperative
at rest in the intervention group was 15
mm lower (28 lower to 1 lower)
- 215 (4 RCTs) ⊕⊕◯◯ LOW
a,b,c,d,e
Pain score 24 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 24 h
postoperative at rest was
28 mm
The mean pain score 24 h
postoperative at rest in the intervention
group was 8 mm lower (17 lower to 0)




with: Number of events
165 per 1,000 297 per 1,000 (209 to 419) RR 1.80
(1.27 to
2.54)




18 per 1,000 35 per 1,000 (3 to 368) RR 1.93
(0.18 to
20.24)




67 per 1,000 383 per 1,000 (163 to 898) RR 5.74
(2.44 to
13.47)
494 (9 RCTs) ⊕⊕⊕⊕HIGH a,b,
h
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the
intervention (and its 95% CI). CI: Confidence interval; MD: Mean difference; RR: Risk ratio
GRADE Working Group grades of evidence: High quality: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different. Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from
the estimate of the effect. Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from
the estimate of effect
a. There were studies of unclear and high summarized risk of bias.
b. There was heterogeneity as noted by I^2.
c. Low assay sensitivity in Olive et al explains the heterogeneity.
d. The intervention did not reach either threshold for significance or a priori estimated information size in trial sequential analysis.
e. 95% confidence interval includes ’no effect’.
f. There were less than 400 participants in total.
h. RR above five.
doi:10.1371/journal.pone.0173107.t004
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The summarized risk of bias was low in one, unclear in five, and high in one trial (Fig 2),
and the trial sample size implicated a high risk of bias in two trials and a moderate risk in five.
L’Abbe´ plots demonstrated homogeneity for morphine consumption and pain scores at rest at
6 hours and higher degrees of heterogeneity at 24 hours (S20 Appendix).
Meta-analyses demonstrated a statistically significant 0–24 hour postoperative morphine
sparing effect of 4.2 mg (95% CI: 1.3 to 7.2; P = 0.004) (Fig 3), and a reduction in pain scores at
rest at 6 hours postoperatively of 10 mm (4 to 17; 0.001) and at 24 hours at rest of 3 mm (-8 to
14; P = 0.57) (Figs 4 and 5).
Table 5. Summarized outcomes in Grading of Recommendations Assessment, Development and Evaluation (GRADE) for each major
intervention.
Table 5 summary of findings:
Local infiltration analgesia compared to Placebo or no intervention for pain after TKA
Patient or population: pain after TKA. Setting: The immediate postoperative setting. Intervention: Local infiltration analgesia. Comparison: Placebo or
no intervention








(GRADE)Risk with Placebo or nointervention
Risk with Local infiltration analgesia
Morphine consumption
assessed with: 0–24 hour
postoperative
The mean morphine
consumption was 38.9 mg
The mean morphine consumption in the
intervention group was 13.4 mg lower
(8.5 lower to 18.2 lower)
- 960 (12 RCTs) ⊕⊕◯◯ LOW a,b
Pain score 6 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 6 h
postoperative at rest was
42 mm
The mean pain score 6 h postoperative
at rest in the intervention group was 14
mm lower (9 lower to 20 lower)
- 959 (13 RCTs) ⊕⊕◯◯ LOW a,b
Pain score 24 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 24 h
postoperative at rest was
36 mm
The mean pain score 24 h postoperative
at rest in the intervention group was 10
mm lower (6 lower to 13 lower)
- 939 (13 RCTs) ⊕⊕◯◯ LOW a,b
Pain score 6 h postoperative
at movement assessed with:
VAS 0–100
The mean pain score 6 h
postoperative at
movement was 50 mm
The mean pain score 6 h postoperative
at movement in the intervention group
was 16 mm lower (9 lower to 23 lower)
- 361 (6 RCTs) ⊕⊕◯◯ LOW a,b
Pain score 24 h postoperative
at movement assessed with:
VAS 0–100
The mean pain score 24 h
postoperative at
movement was 59 mm
The mean pain score 24 h postoperative
at movement in the intervention group
was 14 mm lower (8 lower to 20 lower)
- 377 (6 RCTs) ⊕⊕◯◯ LOW a,b
Postoperative nausea and
vomiting (PONV) assessed
with: Number of events
273 per 1,000 186 per 1,000 (147 to 235) RR 0.68
(0.54 to
0.86)




314 per 1,000 245 per 1,000 (141 to 417) RR 0.78
(0.45 to
1.33)
368 (6 RCTs) ⊕◯◯◯VERY
LOW a,b,c,d
Length of stay (LOS) The mean length of stay
was 5.6 days
The mean length of stay in the
intervention group was 1 days lower
(1.9 lower to 0.2 lower)
- 449 (8 RCTs) ⊕⊕◯◯ LOW a,b
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the
intervention (and its 95% CI). CI: Confidence interval; MD: Mean difference; RR: Risk ratio
GRADE Working Group grades of evidence: High quality: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different. Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from
the estimate of the effect. Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from
the estimate of effect
a. There were studies of unclear and high summarized risk of bias.
b. There was heterogeneity as noted by I^2.
c. There were less than 400 participants in total.
d. 95% confidence interval includes ’no effect’.
doi:10.1371/journal.pone.0173107.t005
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In TSA, reductions in both morphine consumption and pain scores at rest at 6 hours were
above the threshold for significance and reached APIS concluding that intraarticular injection
has a positive effect on these outcomes (S21 Appendix).
In meta-analyses RR for nausea and vomiting was 1.18 (0.51 to 2.74; P = 0.70) (S7 Appen-
dix). Respiratory depression was registered in two trials [67, 69], sinus tachycardia in one [67],
DVT in one [69], wound healing complications in one [69]. No significant differences between
active and control groups were reported.
Quality of evidence (GRADE) was moderate for opioid sparing effect and 6 hours pain
score; low for increase in PONV; and very low for 24 hours pain score. Results are summarized
in Table 6.
Trials were too heterogeneous (administration of different combinations of local anaes-
thetics, morphine, steroids and epinephrine, Table 1) to provide information about optimal
drug-, and dose-regimens.
NSAIDs/COX-2-inhibitors
Ten trials tested NSAIDs/COX-2-inhibitors as an intervention [72–81]. Two of these trials
tested the intervention in addition to a basic analgesic regimen.
Table 6. Summarized outcomes in Grading of Recommendations Assessment, Development and Evaluation (GRADE) for each major
intervention.
Table 6 summary of findings:
Intraarticular injection compared to Placebo or no intervention for pain after TKA
Patient or population: pain after TKA. Setting: The immediate postoperative setting. Intervention: Intraarticular injection. Comparison: Placebo or no
intervention








(GRADE)Risk with Placebo or nointervention
Risk with Intraarticular injection
Morphine consumption





The mean morphine consumption in the
intervention group was 4.2 mg lower
(1.3 lower to 7.2 lower)
- 372 (6 RCTs) ⊕⊕⊕◯
MODERATE a,b
Pain score 6 h postoperative at
rest assessed with: VAS 0–100
The mean pain score 6 h
postoperative at rest was
54 mm
The mean pain score 6 h postoperative
at rest in the intervention group was 10
mm lower (4 lower to 17 lower)
- 261 (5 RCTs) ⊕⊕⊕◯
MODERATE c
Pain score 24 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 24 h
postoperative at rest was
47 mm
The mean pain score 24 h
postoperative at rest in the intervention
group was 3 mm lower (14 lower to 8
higher)




with: Number of events
219 per 1,000 258 per 1,000 (112 to 599) RR 1.18
(0.51 to
2.74)
139 (3 RCTs) ⊕⊕◯◯ LOW c,e,f
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the
intervention (and its 95% CI). CI: Confidence interval; MD: Mean difference; RR: Risk ratio
GRADE Working Group grades of evidence: High quality: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different. Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from
the estimate of the effect. Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from
the estimate of effect
a. There was heterogeneity as noted by I^2.
b. Low assay sensitivity for Browne et al and Safa et al explains heterogeneity however confidence intervals for separate trials are not convincing.
c. There were studies of unclear and high summarized risk of bias.
d. The intervention did not reach either threshold for significance or a priori estimated information size in trial sequential analysis.
e. 95% confidence interval includes ’no effect’.
f. There were less than 400 participants in total.
doi:10.1371/journal.pone.0173107.t006
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The summarized risk of bias was low in zero, unclear in six, and high in four trials (Fig 2)
and the trial sample size implicated a high risk of bias in two trials, a moderate risk in seven
and a very low risk in one. L’Abbe´ plots demonstrated low degrees of heterogeneity for mor-
phine consumption and moderate degrees for pain scores (S22 Appendix).
Meta-analyses demonstrated a statistically significant 0–24 hour postoperative morphine
sparing effect of 6 mg (95% CI: 3.2 to 8.7; P<0.0001) (Fig 3), and a reduction in pain scores at
rest at 6 hours postoperatively of 7 mm (1 to 14; P = 0.02), at 24 hours at rest of 5 mm (3 to 8;
P<0.0001), and at 24 hours during movement of 3 mm (-4 to 10; P = 0.41) (Figs 4 and 5, S6
Appendix).
In TSA, threshold for significance and APIS were reached for morphine consumption and
pain at 6 and 24 hours rest concluding that NSAIDs and COX-2-inhibitors have a positive
effect on these outcomes. The reduction in pain scores during movement at 24 hours reached
the threshold for futility and APIS (S23 Appendix).
In meta-analyses RR for nausea and vomiting was 0.91 (0.61 to 1.35 P = 0.63) and for pruri-
tus 0.91 (0.39 to 2.14; P = 0.83) (S7 and S10 Appendices).
Bleeding was registered in one trial [73], hypo/hypertension in one [74], anemia in two [74,
76], urinary retention in three [74, 76, 78], dry mouth in one [75], gastric pain in one [78] and
constipation, hyperhidrosis, pyrexia, headache and confusion in one [76]. No significant dif-
ferences between active and control groups were reported.
Quality of evidence (GRADE) was low for the opioid sparing effect and reduction in pain
score at 6 and 24 hours at rest, and very low for remaining outcomes. Results are summarized
in Table 7.
Trials were too heterogeneous (time of administration, specific drugs, oral/i.v. administra-
tion) to provide information about optimal drug-, and dose-regimens.
Gabapentinoids
Seven trials tested gabapentinoids as an intervention [81–87]. Six of these trials tested the inter-
vention in addition to a basic analgesic regimen.
The summarized risk of bias was low in three, unclear in two, and high in two trials (Fig 2)
and the trial sample size implicated a high risk of bias in two trials, a moderate risk in four and
a low risk in one. L’Abbe´ plots demonstrated moderate degrees heterogeneity for morphine
consumption and pain scores (S24 Appendix).
Meta-analyses demonstrated non-significant reductions for 0–24 hour postoperative mor-
phine sparing effect of 8.5 mg (95% CI: -3.3 to 20.3; P = 0.16) (Fig 3), and pain scores at rest at
6 hours postoperatively of 4 mm (-1 to 10; P = 0.15) and at 24 hours at rest of 3 mm (-2 to 8;
P = 0.19). Significant reductions in pain scores at 6 and 24 hours during movement of 8 mm (2
to 14; P = 0.01) and 4 mm (0 to 8; P = 0.04), respectively, were demonstrated (Figs 4 and 5, S5
and S6 Appendices).
In TSA, threshold for significance and APIS were reached for pain at 6 and 24 hours during
movement concluding that gabapentinoids have a positive effect on these outcomes. Threshold
for futility and APIS were reached for pain at rest at 6 and 24 hours concluding that further
testing of these outcomes is futile (S25 Appendix).
In meta-analyses RR for nausea and vomiting was 0.83 (0.65 to 1.07, P = 0.15), for sedation
1.17 (0.83 to 1.63, P = 0.37), for dizziness 0.68 (0.3 to 1.53, P = 0.35) and for pruritus 0.3 (0.15
to 0.59; P = 0.0006) (S7–S10 Appendices).
One study reported an accumulation of undesirable reactions due to the study drug in the
intervention groups; lapse of memory function, impaired balance, hypotension, diplopia, seda-
tion, dizziness and fatigue [85].
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Quality of evidence (GRADE) was moderate for pain score at 6 hours at movement; low for
pain scores at 24 hours at rest and during movement, PONV, sedation and pruritus; and very
low for opioid sparing effect, reduction in pain score at 6 hours at rest and dizziness. Results
are summarized in Table 8.
Trials were too heterogeneous (time of administration and specific drugs) to provide infor-
mation about optimal drug-, and dose-regimens.
Qualitative analyses
Forty-one trials investigated other interventions: Adductor canal block [88–91]; clonidine, tra-
madol, fentanyl, magnesium or buprenorphine added to FNB [92–95]; single and continuous
sciatic plexus nerve block [96–100]; obturator nerve block [101, 102]; continuous lumbar
plexus block [103]; morphine, ketamine or epinephrine added to intraarticular injections of
local anaesthetics [104–107]; continuous intraarticular injection of local anaesthetics [108–
110]; ketorolac added to periarticular injection of local anaesthetic [111]; steroids added to
Table 7. Summarized outcomes in Grading of Recommendations Assessment, Development and Evaluation (GRADE) for each major
intervention.
Table 7 summary of findings:
NSAIDs or COX-2-inhibitors compared to Placebo or no intervention for pain after TKA
Patient or population: pain after TKA. Setting: The immediate postoperative setting. Intervention: NSAIDs or COX-2-inhibitors. Comparison: Placebo
or no intervention








(GRADE)Risk with Placebo or nointervention
Risk with NSAIDs or COX-2-inhibitors
Morphine consumption
assessed with: 0–24 hour
postoperative
The mean morphine
consumption was 24.8 mg
The mean morphine consumption in the
intervention group was 6 mg lower (3.2
lower to 8.7 lower)
- 533 (6 RCTs) ⊕⊕◯◯ LOW
a,b
Pain score 6 h postoperative at
rest assessed with: VAS
0–100
The mean pain score 6 h
postoperative at rest was
23 mm
The mean pain score 6 h postoperative
at rest in the intervention group was 7
mm lower (15 lower to 1 higher)
- 408 (6 RCTs) ⊕⊕◯◯ LOW
a,b,c
Pain score 24 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 24 h
postoperative at rest was
28 mm
The mean pain score 24 h postoperative
at rest in the intervention group was 6
mm lower (3 lower to 8 lower)
- 408 (6 RCTs) ⊕⊕◯◯ LOW
a,b
Pain score 24 h postoperative
at movement assessed with:
VAS 0–100
The mean pain score 24 h
postoperative at movement
was 46 mm
The mean pain score 24 h postoperative
at movement in the intervention group
was 3 mm lower (10 lower to 4 higher)





with: Number of events
234 per 1,000 213 per 1,000 (143 to 316) RR 0.91
(0.61 to
1.35)





115 per 1,000 104 per 1,000 (45 to 245) RR 0.91
(0.39 to
2.14)
849 (3 RCTs) ⊕◯◯◯
VERY LOW
a,b,c
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the
intervention (and its 95% CI). CI: Confidence interval; MD: Mean difference; RR: Risk ratio
GRADE Working Group grades of evidence:High quality: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different. Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from
the estimate of the effect. Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from
the estimate of effect
a. There were studies of unclear and high summarized risk of bias.
b. There was heterogeneity as noted by I^2.
c. 95% confidence interval includes ’no effect’.
doi:10.1371/journal.pone.0173107.t007
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Table 8. Summarized outcomes in Grading of Recommendations Assessment, Development and Evaluation (GRADE) for each major
intervention.
Table 8 summary of findings:
Gabapentinoids compared to Placebo or no intervention for pain after TKA
Patient or population: pain after TKA. Setting: The immediate postoperative setting. Intervention: Gabapentinoids. Comparison: Placebo or no
intervention








(GRADE)Risk with Placebo or nointervention
Risk with Gabapentinoids
Morphine consumption
assessed with: 0–24 hour
postoperative
The mean morphine
consumption was 45.6 mg
The mean morphine consumption in the
intervention group was 8.5 mg lower
(20.3 lower to 3.3 higher)
- 238(3 RCTs) ⊕◯◯◯VERY
LOW a,b,c,d
Pain score 6 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 6 h
postoperative at rest was
29 mm
The mean pain score 6 h postoperative at
rest in the intervention group was 4 mm
lower (10 lower to 1 higher)
- 352 (3 RCTs) ⊕◯◯◯VERY
LOW a,b,d
Pain score 24 h postoperative
at rest assessed with: VAS
0–100
The mean pain score 24 h
postoperative at rest was
29 mm
The mean pain score 24 h postoperative
at rest in the intervention group was 3
mm lower (8 lower to 2 higher)
- 388 (4 RCTs) ⊕⊕◯◯ LOW a,d
Pain score 6 h postoperative
at movement assessed with:
VAS 0–100
The mean pain score 6 h
postoperative at
movement was 45 mm
The mean pain score 6 h postoperative at
movement in the intervention group was
8 mm lower (2 lower to 14 lower)
- 352 (3 RCTs) ⊕⊕⊕◯
MODERATE a
Pain score 24 h postoperative
at movement assessed with:
VAS 0–100
The mean pain score 24 h
postoperative at
movement was 51 mm
The mean pain score 24 h postoperative
at movement in the intervention group
was 4 mm lower (0.1 lower to 8 lower)
- 517 (4 RCTs) ⊕⊕◯◯ LOW a,d
Postoperative nausea and
vomiting (PONV) assessed
with: Number of events
374 per 1,000 311 per 1,000 (243 to 401) RR 0.83
(0.65 to
1.07)
497 (6 RCTs) ⊕⊕◯◯ LOW a,d
Sedation assessed with:
Number of events
267 per 1,000 312 per 1,000 (221 to 435) RR 1.17
(0.83 to
1.63)




417 per 1,000 283 per 1,000 (125 to 638) RR 0.68
(0.30 to
1.53)




282 per 1,000 84 per 1,000 (42 to 166) RR 0.30
(0.15 to
0.59)
382 (5 RCTs) ⊕⊕◯◯ LOW
a,b,e,f
Length of stay (LOS) The mean length of stay
was 2.9 days
The mean length of stay in the
intervention group was 0.1 days higher
(0.7 lower to 0.9 higher)
- 490 (3 RCTs) ⊕⊕◯◯ LOW b,d
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the
intervention (and its 95% CI). CI: Confidence interval; MD: Mean difference; RR: Risk ratio
GRADE Working Group grades of evidence: High quality: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different. Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from
the estimate of the effect. Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from
the estimate of effect
a
. There were studies of unclear and high summarized risk of bias.
b
. There was heterogeneity as noted by I^2.
c
. The intervention did not reach either threshold for significance or a priori estimated information size in trial sequential analysis.
d
. 95% confidence interval includes ’no effect’.
e
. There were less than 400 participants in total.
f
. RR below 0.5.
doi:10.1371/journal.pone.0173107.t008
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LIA [112–114]; epidural analgesia with ropivacaine and morphine [115]; magnesium, midazo-
lam or morphine added to epidural bupivacaine/ropivacaine [116, 117]; fentanyl patch [118,
119]; i.v. tramadol [120]; i.v. nefopam [121]; i.v. ketamine [121–123]; p.o. nimodipine [124]; i.
v. dexmedetomidine [125]; i.v. duloxetine [126]; i.v. methyl-prednisolone [127]; and i.v. mag-
nesium [128].
Twenty-four interventions were administered together with a basic analgesic regimen (S4
Appendix).
The risk of bias was low in 12 trials, unclear in 25, and high in four.
Nine trials did not demonstrate a significant effect on opioid consumption and/or pain
scores: Clonidine, tramadol or buprenorphine added to FNB [92, 93, 95]; continuous lumbar
plexus block [103]; morphine, ketamine or epinephrine added to intraarticular local anaes-
thetics [104, 106, 107]; betamethasone added to periarticular local anaesthetics [114]; and i.v.
magnesium [128]. The remaining trials demonstrated statistically significant analgesic effects.
Four trials demonstrated a statistically significant effect on opioid-related adverse events: Sci-
atic nerve block a reduction in PONV [97, 98], dexmedetomidine a reduction in PONV and
pruritus [125], and epidural analgesia with ropivacaine and morphine an increase in pruritus
[115] (Table 9).
Discussion
We have reviewed randomized controlled trials regarding postoperative analgesia after TKA,
and have demonstrated analgesic effects in meta-analyses for single injection- and continuous
FNB, intrathecal morphine, LIA, intraarticular injection of local anaesthetics, NSAIDs/COX-2
inhibitors, and gabapentinoids; and furthermore in stand-alone trials for a number of different
interventions, according to the PRISMA checklist (S26 Appendix). By conducting meta-analy-
ses we have enhanced the evidence to the highest level possible with the present trials. While
this sounds promising, the quality of evidence throughout the included data is discouragingly
low due to uncertain or high risk of bias, low sample size in trials and meta-analysis interven-
tions, heterogeneous results, and low assay sensitivity. These findings are similar to the results
in our recent systematic review on pain management after THA [2]. Consequently, we have
demonstrated that no optimal strategy for postoperative pain treatment after TKA exist in the
literature.
The accepted level of pain varies in the analyzed material. In some trials no basic analgesic
regimens were provided and high pain scores were accepted, whereas in other trials acetamin-
ophen, NSAIDs, gabapentin, and even FNB were administered as adjuncts to the intervention.
In these trials both intervention- and control groups tended to have lower pain scores. These
differences lead to a considerable variance in assay sensitivity amongst trials. The wide varia-
tion in trial-setup may be accounted for by cultural or tradition based differences in the
approach to analgesic treatment, e.g. the propensity to apply invasive procedures or the general
pain threshold.
Interpretation of meta-analysed interventions
For oral treatments we analyzed two subgroups: NSAIDs/COX-2-inhibitors and
gabapentinoids.
The included trials in the NSAID subgroup were characterized by low assay sensitivity,
which contributes to a low absolute effect. However, the intervention provided a small but sta-
tistically significant effect on pain scores and morphine consumption. The adverse event pro-
file of NSAIDs is controversial and short follow up periods in randomized pain trials in
general may be problematic for the detection hereof (17). However, the meta-analyses did not
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demonstrate an increased risk of adverse effects which is supported by similar results in the
review regarding THA [2].
The evidence regarding gabapentinoids was even less convincing, with insignificant results
partially due to a low number of included trials.
Four meta-analysed interventions investigated procedure specific local anaesthetic inter-
ventions: single FNB, continuous FNB, LIA, and intraarticular injection of local anaesthetics.
When reviewing the outcomes, intraarticular injection tended to be inferior compared to the
other interventions.
Single FNB performed slightly better in two out of three primary outcomes compared to
continuous FNB. The strength of evidence in TSA was generally high for both interventions.
Continuous FNB is a more invasive, time consuming and for the patient cumbersome proce-
dure due to the postoperative catheterization.
Single FNB and LIA provided equally satisfying analgesia. Both procedures demonstrated a
relevant reduction in morphine consumption, pain scores and PONV. A recent systematic
review of trials comparing LIA to FNB after TKA reported a small insignificant difference in
analgesic effect favoring LIA [129]. The current evidence does not allow designation of a supe-
rior intervention amongst the two, but the well-known risk of motor blockade with FNB may
render this method less attractive [130]. It should be noted that different combinations of
drugs and dosages were administered for both FNB and LIA. Pinpointing optimal analgesics
regimens for FNB and LIA are imperative for designation of a superior intervention.
The meta-analysis of intrathecal morphine demonstrated some analgesic effect on mor-
phine consumption and pain scores, but a rather large increase in morphine related adverse
events.
Strengths and limitations
The large amounts of data in this review were manually typed with more than 12.000 separate
boxes in Excel1, creating a major potential for typing errors. To minimize this risk data were
analyzed and registered by two independent authors with prior data extraction experience,
and subsequently compared.
In a considerable number of trials data were presented as medians and range/IQR, likely
because of a skewed distribution. Treating data as normally distributed by converting to
mean/SD was necessary, but nonetheless a limitation.
About half of the corresponding authors replied our emails regarding bias. This resolved 74
unclear domains and altered the total number of trials with low summarized risk of bias from
six to 15. This is still only 13% of all trials. For trials included in meta-analyses this proportion
was 7%, which is problematic as the quality of the meta-analyses is partially limited by the
quality of the trials. The majority of trials had an unclear summarized risk of bias. We believe
that in most of these trials, relatively few and easily attainable measures would be required to
improve this risk from unclear to low, especially if authors had access to a standardized post-
operative pain trial protocol that took into account the pitfalls leading to high or unclear risk
of bias.
Opioid consumption and pain intensity are associated, hence both outcomes require assess-
ment. Whether opioid consumption and pain should be calculated as absolute or relative dif-
ferences between treatment and control groups, or as the number of patients with a predefined
level of pain, is controversial. In this review we chose to report effects as absolute (mean) dif-
ferences, which may be arguable.
The majority of included interventions each provided acceptable levels of analgesia, how-
ever it is probably reasonable to keep postoperative analgesic treatment to a limited number of
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interventions. Each additional intervention added to the standard postoperative analgesic regi-
men may increase the risk of adverse effects or events [131]. Regarding invasive procedures we
must consider the risk of inducing severe adverse effects and the time consumption by quali-
fied personnel such as doctors. Furthermore, we know little about the effect of combining dif-
ferent analgesic interventions after TKA [132]. Thus, the absolute analgesic effect may decline
for each additional analgesic, because different interventions may affect the same analgesic
pathways, and because the analgesic potential is probably lower when pain levels are already
reduced by other analgesics.
In conclusion, no gold treatment for pain treatment after TKA exists in the literature. The
GRADE rated recommendations varied from very low to moderate (except for one high) for
the different interventions. High or unclear risk of bias, heterogeneity of trial designs, and the
small trial sample sizes, are challenges in designation of a best proven optimal postoperative
analgesic regimen for TKA. A way to overcome these challenges may be to establish standard
research guidelines regarding postoperative pain management, and focus on conducting high
quality upscale trials.
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(PDF)
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